Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 0.65 |
| ▸ | F3 | P13726 | 1/20 | 0.65 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.61 |
| ▸ | PYGL | P06737 | 1/20 | 0.52 |
| ▸ | NHERF1 | O14745 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9788942 | 1.00 | F7 (0.65) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL24067322 | 0.88 | F7 (0.69) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL25261694 | 0.84 | NR4A2 (0.62) | NR4A2ALDH1A1KMT2A | |
| SCHEMBL26261524 | 0.83 | NR4A2 (0.62) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL26261554 | 0.83 | NR4A2 (0.62) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL25259281 | 0.83 | NR4A2 (0.62) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL30457844 | 0.83 | NR4A2 (0.62) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL25305847 | 0.82 | KDM4E (0.55) | NR4A2ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL25306279 | 0.82 | NR4A2 (0.60) | F7F3NR4A2PYGLNHERF1 | |
| SCHEMBL25742072 | 0.80 | NR4A2 (0.58) | F7F3NR4A2PYGLNHERF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444283-A1 | SPECIALIZED COMBINATIONS FOR MENTAL DISORDERS OR MENTAL ENHANCEMENT | Tactogen Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023107715-A1 | SPECIALIZED COMBINATIONS FOR MENTAL DISORDERS OR MENTAL ENHANCEMENT | TACTOGEN INC (US) | 2023-06-15 | — | — | WO | disclosed |